Nitric oxide impairs the 17β-estradiol-induced apoptosis in human colon adenocarcinoma cells

Endocrine-Related Cancer

Volumn 13, Issue 2, 2006, Pages 559-569

  Marino, M ^a   Galluzzo, P ^a   Leone, S ^a   Acconcia, F ^a,b   Ascenzi, P ^a  

^a ROMA TRE UNIVERSITY   (Italy)

^b EAST TEXAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL VIABILITY; CHEMICAL MODIFICATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; ELECTROPHORESIS; GASTROINTESTINAL MOTILITY; GENETIC TRANSFECTION; GENOME; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOBLOTTING; INCIDENCE; INFECTION; OXIDATION REDUCTION REACTION; PLASMID; STATISTICAL ANALYSIS; TRANSCRIPTION INITIATION;

ADENOCARCINOMA; APOPTOSIS; CASPASE 3; CASPASES; COLONIC NEOPLASMS; CYSTEINE; ENZYME ACTIVATION; ESTRADIOL; ESTROGEN RECEPTOR BETA; HUMANS; NITRIC OXIDE; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 33745173166     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.1.01106     Document Type: Article

References (50)

1. Acconcia F, Ascenzi P, Bocedi A, Spisni E, Tomasi V, Trentalance A, Visca P & Marino M 2005a Palmitoylation-dependent estrogen receptor α membrane localization: regulation by 17β-estradiol. Molecular Biology of the Cell 16 231-237.
2. Acconcia F, Totta P, Ogawa S, Cardillo I, Inoue S, Leone S, Trentalance A, Muramatsu M & Marino M 2005b Survival versus apoptotic 177beta;-estradiol effect: role of ERα and ERβ activated non-genomic signaling. Journal of Cellular Physiology 203 193-201.
3. Acevedo ML & Kraus WL 2004 Trancriptional activation by nuclear receptors. In Essays in Biochemistry - The Nuclear Receptor Superfamily, pp.73-88. Ed. IJ McEwan. Oxford: Portland Press Ltd.
4. Akaike T & Maeda H 2000 Nitric oxide and virus infection. Immunology 101 300-308.
5. al-Azzawi F & Wahab M 2002 Estrogen and colon cancer: current issues. Climacteric 5 3-14.
6. Ascenzi P, Bocedi A & Gradoni L 2003 The anti-parasitic effects of nitric oxide. IUBMB Life 55 573-578.
7. Ascenzi P, Bocedi A, Polticelli F & Bolognesi M 2005 Structural consensus rules for cysteine protease inhibition by NO(-donors). Current Enzyme Inhibition 1 11-20.
8. Bardin A, Boulle N, Lazennec G, Vignon F & Pujol P 2004 Loss of ERβ expression as a common step in estrogen-dependent tumor progression. Endocrine-Related Cancer 11 537-551.
9. Beckman J & Koppenol W 1996 Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. American Journal of Physiology 271 C1424-C1437.
10. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR & Snyder SH 1991 Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351 714-718.
11. Burkman RT 2002 Reproductive hormones and cancer: ovarian and colon cancer. Obstetrics and Gynecology Clinics of North America 29 527-540.
12. Colasanti M, Persichini T, Venturini G & Ascenzi P 1999 S-nitrosylation of viral proteins: molecular bases for antiviral effect of nitric oxide. IUBMB Life 48 25-31.
13. Denninger J & Marletta M 1999 Guanylate cyclase and the NO/cGMP signaling pathway. Biochimica et Biophysica Acta 1411 334-350.
14. Di Leo A, Messa C, Cavallini A & Linsalata M 2001 Estrogens and colorectal cancer. Current Drug Targets -Immune, Endocrine and Metabolic Disorders 1 1-12.
15. Fang FC 2004 Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nature Reviews Microbiology 2 820-832.
16. Felley-Bosco E, Bender F & Quest AF 2002 Caveolin-1-mediated post-transcriptional regulation of inducible nitric oxide synthase in human colon carcinoma cells. Biological Research 35 169-176.
17. Fiorelli G, Picariello L, Martineti V, Tonelli F & Brandi ML 1999 Functional estrogen receptor β in colon cancer cells. Biochemical and Biophysical Research Communications 261 521-527.
18. Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O & Rice LW 2000 Selective loss of estrogen receptor β in malignant human colon. Cancer Research 60 245-248.
19. Garban HJ, Marquez-Garban DC, Pietras RJ & Ignarro LJ 2005 Rapid nitric oxide-mediated S-nitrosylation of estrogen receptor: regulation of estrogen-dependent gene transcription. PNAS 102 2632-2636.
20. Green DR 2005 Apoptotic pathways: ten minutes to dead. Cell 121 671-674.
21. Jaffrey S, Erdjument-Bromage H, Ferris C, Tempst P & Snyder S 2001 Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nature Cell Biology 3 193-197.
22. Kim KH & Bender JR 2005 Rapid, estrogen receptor-mediated signaling: why is the endothelium so special? Science's Signal Transduction Knowledge Environment 288 pe28.
23. Koehler KF, Helguero LA, Haldosen LA, Warner M & Gustafsson J-Å 2005 Reflections on the discovery and significance of estrogen receptor β. Endocrine Reviews 26 465-478.
24. Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andricopoulos P, Varakis I, Sotiropoulou-Bonikou G & Papavassiliou AG 2003 Oestrogen receptor β (ERβ) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. European Journal of Cancer 39 1251-1258.
25. Levin ER 2005 Integration of the extranuclear and nuclear actions of estrogen. Molecular Endocrinology 19 1951-1959.
26. Li J, Billiar TR, Talanian RV & Kim YM 1997 Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochemical and Biophysical Research Communications 240 419-424.
27. Maeda H & Akaike T 1998 Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry (Moscow) 63 854-865.
28. 3-PKC-α signal transduction in HepG2 cells. Biochemical and Biophysical Research Communications 245 254-258.
29. Marino M, Ficca R, Ascenzi P & Trentalance A 2001 Nitric oxide inhibits selectively the 7beta-estradiol-induced gene expression without affecting nongenomic events in HeLa cells. Biochemical and Biophysical Research Communications 286 529-533.
30. 1 gene transcription in HepG2 cells. Molecular Biology of the Cell 13 3720-3729.
31. Marino M, Acconcia F & Trentalance A 2003 Biphasic estradiol-induced AKT phosphorylation is modulated by PTEN via MAP kinase in HepG2 cells. Molecular Biology of the Cell 14 2583-2591.
32. Marino M, Acconcia F & Ascenzi P 2005 Estrogen receptor signalling: bases for drug actions. Current Drug Targets - Immune, Endocrine and Metabolic Disorders 5 305-314.
33. Martineti V, Picariello L, Tognarini I, Sala SC, Gozzini A, Azzari C, Mavilia C, Tanini A, Falchetti A, Fiorelli G, Tonelli F & Brandi ML 2005 ERβ is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components. Endocrine-Related Cancer 12 455-469.
34. Nathan C 2004 The moving frontier in nitric oxide-dependent signaling. Science's Signal Transduction Knowledge Environment 257 pe52.
35. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M & Gustafsson J-Å 2001 Mechanisms of estrogen action. Physiological Reviews 81 1535-1565.
36. Pace P, Taylor J, Suntharalingam S, Coombes RC & Ali S 1997 Human estrogen receptor β binds DNA in a manner similar to and dimerizes with estrogen receptor α. Journal of Biological Chemistry 272 25832-25838.
37. Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL & Leitman DC 2004 Estrogen receptor β inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Research 64 423-428.
38. Qiu Y, Waters CE, Lewis AE, Langman MJ & Eggo MC 2002 Oestrogen-induced apoptosis in colonocytes expressing oestrogen receptor β. Journal of Endocrinology 174 369-377.
39. Qiu Y, Langman MJ & Eggo MC 2004 Targets of 17β-oestradiol- induced apoptosis in colon cancer cells: a mechanism for the protective effects of hormone replacement therapy? Journal of Endocrinology 181 327-337.
40. Rossig L, Fichtischerer B, Breitschopf K, Haendeler J, Zeiher AM, Mulsch A & Dimmeler S 1999 Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. Journal of Biological Chemistry 274 6823-6826.
41. Shah S, Nathan L, Singh R, Fu YS, Chaudhuri G 2001 E2 and not P4 increases NO release from NANC nerves of the gastrointestinal tract: implications in pregnancy. American Journal of Physiology: Regulative, Integrative, and Comparative Physiology 280 R1546-R1554.
42. Shah V, Lyford G, Gores G & Farrugia G 2004 Nitric oxide in gastrointestinal health and disease. Gastroenterology 126 903-913.
43. Stamler J, Lamas S & Fang F 2001 Nitrosylation: the prototypic redox based signaling mechanism. Cell 106 675-683.
44. Strom A, Hartman J, Foster JS, Kietz S, Wimalasena J & Gustafsson J-Å 2004 Estrogen receptor beta inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D. PNAS 101 1566-1571.
45. Wang ZB, Liu YQ & Cui YF 2005 Pathways to caspase activation. Cell Biology International 29 489-496.
46. Weihua Z, Andersson S, Cheng G, Simpson ER, Warner M & Gustafsson J-Å 2003 Update on estrogen signaling. FEBS Letters 546 17-24.
47. Wesierska-Gadek J, Gueorguieva M, Wojciechowski J & Tudzarova-Trajkovska S 2004 In vivo activated caspase-3 cleaves PARP-1 in rat liver after administration of the hepatocarcinogen N-Nitrosomorpholine (NNM) generating the 85kDa fragment. Journal of Cellular Biochemistry 93 774-787.
48. Zaki MH, Akuta T & Akaike T 2005 Nitric oxide-induced nitrative stress involved in microbial pathogenesis. Journal of Pharmacological Sciences 98 117-129.
49. Zech B, Wilm M, van Eldik R & Brune B 1999 Mass spectrometric analysis of nitric oxide-modified caspase-3. Journal of Biological Chemistry 274 20931-20936.
50. Zheng J, Ali A & Ramirez VD 1996 Steroids conjugated to bovine serum albumin as tools to demonstrate specific steroid neuronal membrane binding sites. Journal of Psychiatry and Neurosciences 21 187-197.